BR0308040A - Composições farmacêuticas e cosméticas compreendendo plgf-1 - Google Patents

Composições farmacêuticas e cosméticas compreendendo plgf-1

Info

Publication number
BR0308040A
BR0308040A BR0308040-4A BR0308040A BR0308040A BR 0308040 A BR0308040 A BR 0308040A BR 0308040 A BR0308040 A BR 0308040A BR 0308040 A BR0308040 A BR 0308040A
Authority
BR
Brazil
Prior art keywords
plgf
cosmetic compositions
pharmaceutical
compositions
scleroderma
Prior art date
Application number
BR0308040-4A
Other languages
English (en)
Inventor
Domenico Maglione
Mauro Battisti
Ettore Conti
Guiseppe Salvia
Marina Tucci
Original Assignee
Geymonat Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11456138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308040(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geymonat Spa filed Critical Geymonat Spa
Publication of BR0308040A publication Critical patent/BR0308040A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS E COSMéTICAS COMPREENDENDO PLGF-1". A invenção refere-se à preparação de fator de crescimento placentário (PLGF), a qual compreende composições terapêuticas e cosméticas capazes de aumentar a angiogênese do tecido conectivo cutâneo, subcutâneo e de órgãos internos. Tais composições são adequadas para o tratamento de estados patológicos ou naturais que se beneficiam da formação ou regeneração de novos vasos da região cutânea, tal como esclerodermia, suas diversas manifestações, envelhecimento da pele e queda de cabelo.
BR0308040-4A 2002-03-05 2003-03-05 Composições farmacêuticas e cosméticas compreendendo plgf-1 BR0308040A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000119A ITRM20020119A1 (it) 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
PCT/IT2003/000132 WO2003074075A1 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1

Publications (1)

Publication Number Publication Date
BR0308040A true BR0308040A (pt) 2004-12-14

Family

ID=11456138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308040-4A BR0308040A (pt) 2002-03-05 2003-03-05 Composições farmacêuticas e cosméticas compreendendo plgf-1

Country Status (20)

Country Link
US (1) US7364722B2 (pt)
EP (1) EP1482967B1 (pt)
JP (2) JP5010093B2 (pt)
KR (1) KR100988656B1 (pt)
CN (1) CN100467058C (pt)
AU (1) AU2003217464B2 (pt)
BR (1) BR0308040A (pt)
CA (1) CA2477075C (pt)
CY (1) CY1114209T1 (pt)
DK (1) DK1482967T3 (pt)
ES (1) ES2424827T3 (pt)
HR (1) HRP20040914A2 (pt)
IT (1) ITRM20020119A1 (pt)
MX (1) MXPA04008486A (pt)
PL (1) PL371788A1 (pt)
PT (1) PT1482967E (pt)
RU (1) RU2292906C2 (pt)
SI (1) SI1482967T1 (pt)
WO (1) WO2003074075A1 (pt)
ZA (1) ZA200407707B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872040B1 (fr) * 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
BRPI1008815A2 (pt) * 2009-02-05 2018-02-14 Digna Biotech, S.L composições farmacêuticas compreendendo peptídeos inibidores de tgf-beta1
US8741850B2 (en) 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
US10729746B2 (en) 2013-01-28 2020-08-04 Shire Human Genetic Therapies, Inc. Recombinant placenta growth factor for treating Duchenne muscular dystrophy
EP3094336A4 (en) 2014-01-17 2018-02-14 MIMEDX Group Inc. Method for inducing angiogenesis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1283892A (en) * 1970-06-08 1972-08-02 Irwin Irville Lubowe Improvements in and relating to medicinal compositions for application to the skin and/or hair
IT1242149B (it) 1990-09-27 1994-02-16 Consiglio Nazionale Ricerche Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
EP0845992B1 (en) * 1995-08-15 2002-11-20 Connetics Corporation Use of relaxin for promoting angiogenesis
RU2102091C1 (ru) * 1995-09-19 1998-01-20 Казанский медицинский университет Способ лечения системной склеродермии
WO1997048405A1 (fr) * 1996-06-21 1997-12-24 Jury Evgenievich Belyaev Produit semi-fini permettant d'obtenir des bases de medicaments, bases de medicaments obtenues a l'aide ce dernier et variantes, et medicament faisant appel a ces bases et variantes
CN1345247A (zh) * 1997-12-24 2002-04-17 路德维格癌症研究所 表达血管内皮生长因子d的表达载体和细胞系以及治疗黑素瘤的方法
WO2001000792A1 (en) * 1999-06-29 2001-01-04 Marchosky J Alexander Compositions and methods for forming and strengthening bone
JP3877914B2 (ja) * 1999-09-07 2007-02-07 サンスター株式会社 皮膚化粧料
AU4643501A (en) * 2000-02-04 2001-08-14 Flanders Interuniversity Institute For Biotechnology (Vib) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
JP2001316242A (ja) * 2000-03-02 2001-11-13 Noevir Co Ltd 皮膚外用剤
US6773881B2 (en) * 2000-03-31 2004-08-10 The General Hospital Corporation Methods of modulating hair growth

Also Published As

Publication number Publication date
ITRM20020119A1 (it) 2003-09-05
AU2003217464A1 (en) 2003-09-16
RU2004129586A (ru) 2005-06-10
HRP20040914A2 (en) 2004-12-31
HK1078469A1 (zh) 2006-03-17
US20050239698A2 (en) 2005-10-27
KR20040111379A (ko) 2004-12-31
SI1482967T1 (sl) 2013-10-30
US7364722B2 (en) 2008-04-29
ITRM20020119A0 (it) 2002-03-05
JP5144690B2 (ja) 2013-02-13
AU2003217464B2 (en) 2007-08-30
CA2477075C (en) 2013-08-06
US20050075288A1 (en) 2005-04-07
JP5010093B2 (ja) 2012-08-29
EP1482967B1 (en) 2013-05-15
DK1482967T3 (da) 2013-08-26
CY1114209T1 (el) 2016-08-31
CN1638793A (zh) 2005-07-13
JP2010116405A (ja) 2010-05-27
ZA200407707B (en) 2005-07-27
MXPA04008486A (es) 2005-04-19
CN100467058C (zh) 2009-03-11
PL371788A1 (en) 2005-06-27
KR100988656B1 (ko) 2010-10-18
ES2424827T3 (es) 2013-10-08
EP1482967A1 (en) 2004-12-08
PT1482967E (pt) 2013-08-27
RU2292906C2 (ru) 2007-02-10
CA2477075A1 (en) 2003-09-12
JP2005519101A (ja) 2005-06-30
WO2003074075A1 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
ES2285859T3 (es) Utilizacion cosmetica o dermofarmaceutica de peptidos para la cicatrizacion, la hidratacion y la mejora del aspecto cutaneo durante el envejecimiento natural o acelerado (heliodermia, contaminacion).
BR0211641A (pt) Compostos anti-envelhecimento e de cura de ferimento
DE60028970D1 (de) An her2 bindende peptidverbindungen
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
ATE446313T1 (de) Muteine von tränen-lipocalin
AP2000001905A0 (en) Peptide compositions and formulations and use of same.
CN101111222A (zh) 刺激胶原蛋白合成和/或kgf表达的方法
CY1114209T1 (el) Φαρμακευτικες και καλλυντικες συνθεσεις που περιλαμβανουν plgf-1
CY1109843T1 (el) Αναλογα της βιταμινης d
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
DE69840497D1 (de) Verwendung von Aplidine zur Behandlung von kardiovaskulären Erkrankungen
BR0315437A (pt) Composição para o tratamento dos cabelos, usos da mesma e método para o tratamento dos cabelos
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
ATE322878T1 (de) Biotin enthaltende galenische formulierung
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
ATE427956T1 (de) Ckrox-peptide und ihre analoge zur behandlung von hautalterung
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
NO20006337L (no) Diarylselenidforbindelser og deres anvendelse i human- eller veterinærmedisin og i kosmetikk
DE69824017D1 (de) Vehikel zur gentherapie enthaltend dermales huellgewebe
ATE555787T1 (de) Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
WO1999049895A3 (en) Method for increasing the permeability of horny human tissue

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 38/18 , A61K 7/48 , A61P 17/00 , A61P 17/02 , A61P 17/14

Ipc: A61K 38/18 (2006.01), A61K 8/64 (2006.01), A61P 17

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time